ZYMEWORKS INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.4 USD | +0.53% |
|
+12.23% | -0.19% |
| 17/06 | Zymeworks Says FDA Clears Investigational New Drug Application for Cancer Therapy | MT |
| 17/06 | Zymeworks Gets FDA OK to Study ZW171 for Mesothelin-Expressing Cancers | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ZYMEWORKS INC. | Bio Therapeutic Drugs | +0.19% | +12.23% | -0.19% | +30.11% | -56.79% | 738M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ZYME Stock
- Charts Zymeworks Inc.
- Comparison Chart
